Berikutnya

Putar otomatis

Minimum Residual Disease in Acute Lymphoblastic Leukemia

5 Tampilan • 08/04/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis